European Dividend Stocks With Up To 3.7% Yield For Your Portfolio

As European markets experience a mix of relief from the reopening of the U.S. federal government and tempered enthusiasm due to cooling sentiment on artificial intelligence, investors are keenly observing dividend stocks for stable returns. In such an environment, selecting dividend stocks with attractive yields can provide a reliable income stream while navigating market fluctuations.

Top 10 Dividend Stocks In Europe

Name	Dividend Yield	Dividend Rating
Zurich Insurance Group (SWX:ZURN)	4.34%	★★★★★★
Sonae SGPS (ENXTLS:SON)	4.15%	★★★★★☆
Holcim (SWX:HOLN)	4.35%	★★★★★★
HEXPOL (OM:HPOL B)	5.22%	★★★★★★
Evolution (OM:EVO)	4.93%	★★★★★★
DKSH Holding (SWX:DKSH)	4.34%	★★★★★★
d'Amico International Shipping (BIT:DIS)	9.68%	★★★★★☆
Credito Emiliano (BIT:CE)	5.16%	★★★★★☆
Cembra Money Bank (SWX:CMBN)	4.71%	★★★★★★
Bravida Holding (OM:BRAV)	4.69%	★★★★★★

Click here to see the full list of 225 stocks from our Top European Dividend Stocks screener.

We'll examine a selection from our screener results.

De'Longhi (BIT:DLG)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: De'Longhi S.p.A. is a company that produces and distributes a range of household appliances, including coffee machines, food preparation and cooking devices, air conditioning and heating systems, as well as domestic cleaning and ironing products, with a market cap of approximately €5.10 billion.

Operations: De'Longhi S.p.A.'s revenue is generated from its diverse range of household appliances, which include coffee machines, food preparation and cooking devices, air conditioning and heating systems, as well as domestic cleaning and ironing products.

Dividend Yield: 3.7%

De'Longhi's recent earnings guidance revision indicates a positive outlook, with expected revenue growth between 7.5% and 8.5% for 2025. The company's dividends are covered by both earnings (payout ratio: 58.5%) and cash flows (cash payout ratio: 67.3%), although its dividend yield of 3.66% is below the top tier in Italy at 4.88%. Despite past volatility in dividend payments, De'Longhi has shown consistent profit growth, reporting €2.46 billion in sales for the first nine months of 2025 compared to €2.23 billion last year, with net income rising to €187.6 million from €173.8 million.

• Navigate through the intricacies of De'Longhi with our comprehensive dividend report here.
• In light of our recent valuation report, it seems possible that De'Longhi is trading beyond its estimated value.

Clínica Baviera (BME:CBAV)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Clínica Baviera, S.A. operates a network of ophthalmology clinics across Spain and Europe, with a market cap of €685.31 million.

Operations: Clínica Baviera, S.A. generates its revenue primarily from its ophthalmology clinics, amounting to €288.92 million.

Dividend Yield: 3.7%

Clínica Baviera's dividends are supported by earnings (payout ratio: 62.5%) and cash flows (cash payout ratio: 61.1%), though its dividend yield of 3.73% is modest compared to Spain's top payers at 5.38%. While the Price-To-Earnings ratio of 17.6x suggests fair valuation, the dividend history has been unstable with significant volatility over the past decade despite some growth in payments, raising concerns about reliability for income-focused investors.

• Get an in-depth perspective on Clínica Baviera's performance by reading our dividend report here.
• The valuation report we've compiled suggests that Clínica Baviera's current price could be inflated.

Biofarm (BVB:BIO)

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Biofarm S.A. is a Romanian company that manufactures and sells medicines, with a market cap of RON823.77 million.

Operations: Biofarm S.A. generates revenue primarily from its Pharmaceuticals segment, amounting to RON308.52 million.

Dividend Yield: 3.7%

Biofarm's dividend payments are well-supported by earnings (payout ratio: 37.6%) and cash flows (cash payout ratio: 40.4%), ensuring sustainability and reliability over the past decade with consistent growth. Despite a modest yield of 3.71%, lower than Romania's top payers at 6.41%, Biofarm offers value trading at 45.8% below estimated fair value, alongside strong financial performance, evidenced by a recent increase in net income to RON 87.06 million for the first nine months of 2025.

• Delve into the full analysis dividend report here for a deeper understanding of Biofarm.
• The analysis detailed in our Biofarm valuation report hints at an deflated share price compared to its estimated value.

Next Steps

• Take a closer look at our Top European Dividend Stocks list of 225 companies by clicking here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com